Rajesh Jain, joint managing director, Panacea Biotec expects the USFDA approval for the collaborated drug by next year to early-2016.
first published: Dec 19, 2014 03:00 pm
A collection of the most-viewed Moneycontrol videos.

Nifty Tests 25,900 But Stages Smart Recovery From Day's Low | Closing Bell Live | 4K

The Bihar conundrum- freebies Vs Growth with NK Singh, Economist and Former MP

Will Nifty Cross 26,100 Hurdle On Weekly F&O Expiry? PhysicsWallah Lists Today|Opening Bell Live

How SIP Top-Ups Can Boost Your Wealth | Smart Investing Made Simple
You are already a Moneycontrol Pro user.

